# Electrochemotherapy With Carboplatinum Plus Bleomycin Versus Bleomycin Alone in Vulvar Cancer

> **NCT05395962** · PHASE2 · RECRUITING · sponsor: **IRCCS Azienda Ospedaliero-Universitaria di Bologna** · enrollment: 92 (estimated)

## Conditions studied

- Vulvar Cancer

## Interventions

- **DRUG:** Carboplatin
- **DRUG:** Bleomycin

## Key facts

- **NCT ID:** NCT05395962
- **Lead sponsor:** IRCCS Azienda Ospedaliero-Universitaria di Bologna
- **Sponsor class:** OTHER
- **Phase:** PHASE2
- **Study type:** INTERVENTIONAL
- **Status:** RECRUITING
- **Start date:** 2022-04-08
- **Primary completion:** 2025-04-07
- **Final completion:** 2027-04-07
- **Target enrollment:** 92 (ESTIMATED)
- **Last updated:** 2022-05-27


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT05395962

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT05395962, "Electrochemotherapy With Carboplatinum Plus Bleomycin Versus Bleomycin Alone in Vulvar Cancer". Retrieved via AI Analytics 2026-07-16 from https://api.ai-analytics.org/clinical/NCT05395962. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*